Literature DB >> 4143017

Spinal-fluid lysozyme in the diagnosis of central-nervous-system tumours.

J Newman, A S Josephson, A Cacatian, A Tsang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4143017     DOI： 10.1016/s0140-6736(74)90946-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Quantitative tear lysozyme assay in units of activity per microlitre.

Authors:  I A Mackie; D V Seal
Journal:  Br J Ophthalmol       Date:  1976-01       Impact factor: 4.638

2.  Detection of intracranial tumours with special reference to immunodiagnosis.

Authors:  K D Bagshawe; S Harland
Journal:  Proc R Soc Med       Date:  1976-01

3.  The value of the measurement of cerebrospinal fluid levels of lysozyme in the diagnosis of neurological disease.

Authors:  G Firth; J Rees; R O McKeran
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-07       Impact factor: 10.154

4.  Enzyme-functionalized biomimetic apatites: concept and perspectives in view of innovative medical approaches.

Authors:  Christina G Weber; Michaela Mueller; Nicolas Vandecandelaere; Iris Trick; Anke Burger-Kentischer; Tanja Maucher; Christophe Drouet
Journal:  J Mater Sci Mater Med       Date:  2013-11-21       Impact factor: 3.896

5.  Lactoferrin, lysozyme, and beta 2-microglobulin levels in cerebrospinal fluid: differential indices of CNS inflammation.

Authors:  R Hällgren; A Terént; P Venge
Journal:  Inflammation       Date:  1982-09       Impact factor: 4.092

6.  [Lysozyme and beta2-microglobulin in cerebrospinal fluids from healthy children and in children with diseases of the central nervous system (author's transl)].

Authors:  D Gekle; J Kult; R Roth
Journal:  Klin Wochenschr       Date:  1977-02-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.